The team developed a tumor-independent test that is used to evaluate genome-wide cell-free DNA fragmentation profiles and repeat landscapes.

The firm touted new assays, provided an update on its nanopore sequencer, and offered insights into upcoming pipeline ...

The firm raised its full-year revenue guidance on expectations of growth in the range of 3 to 5 percent but it maintained its full-year EPS guidance.

The firm's shares rose to $62.17 at the close of Tuesday's trading on news that TPG and Blackstone had offered to take the firm private.

According to the FDA, the tubes are not being produced in conformity with good manufacturing practice and have led to false positive lead test results.

Investors and consultants in the space said that they have seen rising enthusiasm among investors as recent funding rounds ...

NEW YORK – Shares of Hologic jumped 14 percent on Tuesday following a report that the company had rejected an offer totaling more than $16 billion to take it private. Hologic shares rose to $61.66 in ...

Last week, readers were most interested in a story about an MOU between Gene Solutions and NEWCL to establish a lab in Taiwan.